Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A 6 month, open label, prospective, multi centre, international study of a transition to flexibly dose paliperidone palmitate (a second generation antipsychotic) in patients with schizophrenia previously unsuccessfully treated with oral or long acting injectable antipsychotics

Trial Profile

A 6 month, open label, prospective, multi centre, international study of a transition to flexibly dose paliperidone palmitate (a second generation antipsychotic) in patients with schizophrenia previously unsuccessfully treated with oral or long acting injectable antipsychotics

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 12 Dec 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Paliperidone (Primary) ; Paliperidone (Primary)
  • Indications Schizophrenia
  • Focus Registrational; Therapeutic Use
  • Acronyms PALMFlexS
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 04 Feb 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record and as per European Clinical Trials Database record, status is ongoing in Spain and UK and completed in remaining countries, hence status amended as per NCT.
    • 16 Aug 2012 Actual patient number changed from 1046 to 1045 as reported by ClinicalTrials.gov.
    • 07 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top